Title : Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial.

Pub. Date : 2021 Jul-Aug

PMID : 34172394






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bempedoic acid is an oral, once-daily, ATP-citrate lyase inhibitor that significantly lowers LDL-C in patients with hypercholesterolemia when given alone or as add-on therapy to statins and/or ezetimibe. 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid ATP citrate lyase Homo sapiens